Nykredit A/S’s CVS Health CVS Stock Holding History

Nykredit A/S’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280M	Buy	+2,708,631	New	+$242M	0.88%	17

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Nykredit A/S's CVS Position: Q2 2026 in Review

Nykredit A/S opened a new position in CVS Health (CVS) in Q2 2026: 2,708,631 shares worth $280M. The stake represents 0.88% of the portfolio and ranks #17 among its holdings.

1,680 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Nykredit A/S held 2,708,631 shares of CVS Health worth $280M as of Q2 2026.
CVS Health was a new Nykredit A/S position in Q2 2026.
CVS Health made up 0.88% of Nykredit A/S's portfolio in Q2 2026, its #17 holding.
1,680 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.